Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

NCT04458051

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • UC San Diego ACTRI Site Number : 8400101 La Jolla, California, United States
  • Collaborative Neuroscience Research Site Number : 8400045 Los Alamitos, California, United States
  • Multiple Sclerosis Center- Site Number : 8400143 Los Angeles, California, United States
  • Multiple Sclerosis Center of California Site Number : 8400135 Newport Beach, California, United States
View all 277 locations
View Trial Details
Completed

A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)

NCT03933202

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • North Central Neurology Associates, P.C. Cullman, Alabama, United States
  • University of South Alabama Mobile, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Fullerton Neurology and Headache Center Fullerton, California, United States
View all 66 locations
View Trial Details

Related conditions